COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine
Clinical trial NCT04852861 · COMPLETED
Trial details
- NCT number
- NCT04852861
- Sponsor
- Sciensano
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2021-07-31
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.